Appili Therapeutics Inc. (APLIF)
USD 0.03
(0.0%)
USD 0.03
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 | -0.03 CAD | 85.82% |
| 2023 | -0.22 CAD | -4.76% |
| 2022 | -0.21 CAD | 12.5% |
| 2021 | -0.24 CAD | -84.62% |
| 2020 | -0.13 CAD | 7.14% |
| 2019 | -0.14 CAD | -16.67% |
| 2018 | -0.12 CAD | -107.25% |
| 2017 | -0.06 CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.01 CAD | 29.69% |
| 2024 FY | - CAD | 85.82% |
| 2024 Q3 | -0.00 CAD | 90.37% |
| 2024 Q4 | -0.01 CAD | -600.0% |
| 2024 Q1 | -0.02 CAD | 30.18% |
| 2023 Q1 | -0.03 CAD | 45.51% |
| 2023 Q4 | -0.03 CAD | -27.31% |
| 2023 FY | - CAD | -4.76% |
| 2023 Q3 | -0.02 CAD | -60.0% |
| 2023 Q2 | -0.01 CAD | 47.06% |
| 2022 Q2 | -0.18 CAD | -50.0% |
| 2022 FY | - CAD | 12.5% |
| 2022 Q4 | -0.05 CAD | -1.3% |
| 2022 Q3 | -0.05 CAD | 74.33% |
| 2022 Q1 | -0.12 CAD | -51.13% |
| 2021 FY | - CAD | -84.62% |
| 2021 Q3 | -0.07 CAD | -70.65% |
| 2021 Q1 | -0.05 CAD | -58.1% |
| 2021 Q2 | -0.04 CAD | 22.24% |
| 2021 Q4 | -0.08 CAD | -15.74% |
| 2020 FY | - CAD | 7.14% |
| 2020 Q4 | -0.03 CAD | 6.84% |
| 2020 Q3 | -0.04 CAD | -2.63% |
| 2020 Q2 | -0.03 CAD | 42.42% |
| 2020 Q1 | -0.06 CAD | -37.5% |
| 2019 Q1 | -0.01 CAD | 69.94% |
| 2019 FY | - CAD | -16.67% |
| 2019 Q2 | -0.04 CAD | -175.69% |
| 2019 Q3 | -0.04 CAD | 9.32% |
| 2019 Q4 | -0.04 CAD | -20.0% |
| 2018 FY | - CAD | -107.25% |
| 2018 Q4 | -0.05 CAD | -21.88% |
| 2018 Q3 | -0.04 CAD | 0.0% |
| 2017 FY | - CAD | 0.0% |